BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21253785)

  • 1. Allocating cancer-directed expenditures: tensions between prevention, early detection and treatment is unnecessary.
    Hillner BE; Smith TJ
    Recent Results Cancer Res; 2011; 188():1-9. PubMed ID: 21253785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health care expenditures linked to the use of targeted therapies and diagnostic tests for cancer patients].
    Marino P; Bertucci F; Gonçalves A; Seror V
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():19-23. PubMed ID: 22494652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of Cancer: Healthcare Expenditures and Economic Impact.
    Jönsson B
    Recent Results Cancer Res; 2019; 213():7-23. PubMed ID: 30543004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The financial burden of cancer care: do patients in the US know what to expect?
    Peppercorn J
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):835-42. PubMed ID: 25269513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivering affordable cancer care in high-income countries.
    Sullivan R; Peppercorn J; Sikora K; Zalcberg J; Meropol NJ; Amir E; Khayat D; Boyle P; Autier P; Tannock IF; Fojo T; Siderov J; Williamson S; Camporesi S; McVie JG; Purushotham AD; Naredi P; Eggermont A; Brennan MF; Steinberg ML; De Ridder M; McCloskey SA; Verellen D; Roberts T; Storme G; Hicks RJ; Ell PJ; Hirsch BR; Carbone DP; Schulman KA; Catchpole P; Taylor D; Geissler J; Brinker NG; Meltzer D; Kerr D; Aapro M
    Lancet Oncol; 2011 Sep; 12(10):933-80. PubMed ID: 21958503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs of cancer care in the United States: implications for action.
    Schuette HL; Tucker TC; Brown ML; Potosky AL; Samuel T
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):19-22. PubMed ID: 8608052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of cancer care and control in countries of low and middle income: a call to action.
    Farmer P; Frenk J; Knaul FM; Shulman LN; Alleyne G; Armstrong L; Atun R; Blayney D; Chen L; Feachem R; Gospodarowicz M; Gralow J; Gupta S; Langer A; Lob-Levyt J; Neal C; Mbewu A; Mired D; Piot P; Reddy KS; Sachs JD; Sarhan M; Seffrin JR
    Lancet; 2010 Oct; 376(9747):1186-93. PubMed ID: 20709386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal for the breakdown of increased cancer healthcare cost and its improvement.
    Koinuma N
    Jpn J Clin Oncol; 2013 Apr; 43(4):351-6. PubMed ID: 23423810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost considerations in the management of cancer in the older patient.
    McKoy JM; Fitzner KA; Edwards BJ; Alkhatib M; Tigue CC; Nonzee NJ; Bolden CR; Bennett CL
    Oncology (Williston Park); 2007 Jun; 21(7):851-7; discussion 858, 860, 862 passim. PubMed ID: 17722744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medications and financing of health systems in Third World countries. Cost recovery: a concept to review].
    Velasquez G
    Tiers Monde; 1989; 30(118):455-63. PubMed ID: 12316194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of cancer care: the patient perspective.
    Kim P
    J Clin Oncol; 2007 Jan; 25(2):228-32. PubMed ID: 17210945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socio-economic factors and health care system characteristics related to cancer survival in the elderly. A population-based analysis in 16 European countries (ELDCARE project).
    Quaglia A; Vercelli M; Lillini R; Mugno E; Coebergh JW; Quinn M; Martinez-Garcia C; Capocaccia R; Micheli A;
    Crit Rev Oncol Hematol; 2005 May; 54(2):117-28. PubMed ID: 15843094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finance for health care: part of a broad canvas.
    Evlo K; Carrin G
    World Health Forum; 1992; 13(2-3):165-70. PubMed ID: 1418329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of initial cancer care and its affecting factors].
    Kim SY; Kim SG; Park JH; Park EC
    J Prev Med Public Health; 2009 Jul; 42(4):243-50. PubMed ID: 19675401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.
    Stoll M; Claes C; Schulte E; Graf von der Schulenburg JM; Schmidt RE
    Eur J Med Res; 2002 Nov; 7(11):463-71. PubMed ID: 12568973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.